Harnessing Elite Donor Selection Strategies to Enhance HSC-Derived NK Cell Manufacturing Performance
1:45 pm - Tuesday 8th December 2026
- Identifying high-performing donor characteristics to generate potent, consistent HSCderived NK cell products at scale
- Implementing donor screening and qualification frameworks to improve manufacturing success rates and reduce variability
- Leveraging donor-derived cellular attributes alongside expansion technologies to enhance therapeutic efficacy and commercial readiness
